Products
Our Products
HLS is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties.
Product Pipeline |
||||
---|---|---|---|---|
CARDIOVASCULAR (CV) | ||||
Vascepa | CV risk reduction | Canada | Marketed | |
Trinomia | CV risk reduction | Canada | Under review | |
CENTRAL NERVOUS SYSTEM (CNS) | ||||
Clozaril | Schizophrenia | U.S./Canada | Marketed | |
CSAN Pronto | WBC Point-of-Care Diagnostic | Canada | Marketed | |
PERSERIS | Schizophrenia | Canada | Approved and in pre-launch phase | |
MyCare Psychiatry | Psychiatric Therapeutic Drug Monitoring | Canada | Marketed | |
ROYALTY PRODUCTS | ||||
Royalty Portfolio | Multiple Indications | Global | Marketed by third parties |
For U.S. Residents, click here for commercial product information.
For Canadian Residents, please click on the Canadian flag above for more commercial product information.